标题
Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
作者
关键词
-
出版物
Cancers
Volume 9, Issue 12, Pages 87
出版商
MDPI AG
发表日期
2017-07-11
DOI
10.3390/cancers9070087
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Strategies of temozolomide in future glioblastoma treatment
- (2017) Chooi Yeng Lee OncoTargets and Therapy
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
- (2016) Francesca De Bacco et al. EMBO Molecular Medicine
- c-Met–mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma
- (2016) Menggui Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- MINI01.03: Phase (Ph) I Study of the Safety and Efficacy of the cMET Inhibitor Capmatinib (INC280) in Patients with Advanced cMET+ NSCLC
- (2016) Todd M. Bauer et al. Journal of Thoracic Oncology
- In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models
- (2016) Paul E. Hughes et al. MOLECULAR CANCER THERAPEUTICS
- 370 Magnetic Resonance-Guided Focused Ultrasound Delivery of Polymeric Brain-Penetrating Nanoparticle MicroRNA Conjugates in Glioblastoma
- (2016) Rafael A. Vega et al. NEUROSURGERY
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein
- (2015) Anna C. Navis et al. ACTA NEUROPATHOLOGICA
- miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics
- (2015) Fotini M Kouri et al. CELL CYCLE
- miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma
- (2015) Fotini M. Kouri et al. GENES & DEVELOPMENT
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met
- (2015) Fengming Lan et al. JOURNAL OF NEUROCHEMISTRY
- Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis
- (2015) Li Zhen et al. TUMOR BIOLOGY
- A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme
- (2015) Hayley Nehoff et al. Oncotarget
- Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
- (2015) Emily Padfield et al. Frontiers in Oncology
- Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal
- (2015) Hae-Kyung Lee et al. Oncotarget
- Mesenchymal Stem Cells Display Tumor-Specific Tropism in an RCAS/Ntv-a Glioma Model
- (2015) Tiffany Doucette et al. NEOPLASIA
- Regulation of HGF Expression by ΔEGFR-Mediated c-Met Activation in Glioblastoma Cells
- (2015) Jeannine Garnett et al. NEOPLASIA
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B and glioblastoma
- (2014) Y Zhang et al. CELL DEATH AND DIFFERENTIATION
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- c-MET Inhibitors in the Treatment of Lung Cancer
- (2014) Joanna Goździk-Spychalska et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age
- (2014) G Kenneth Gray et al. Expert Review of Neurotherapeutics
- Enhancement of the Tumor Penetration of Monoclonal Antibody by Fusion of a Neuropilin-Targeting Peptide Improves the Antitumor Efficacy
- (2014) T.-H. Shin et al. MOLECULAR CANCER THERAPEUTICS
- Targeting MET for glioma therapy
- (2014) Ahmed J. Awad et al. Neurosurgical Focus
- In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like Cells
- (2014) Prakash Rath et al. Translational Oncology
- Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues
- (2014) Makiko Kawaguchi et al. Cancers
- Cancer Stem Cells and Their Mechanism of Chemo-Radiation Resistance
- (2014) Yonghyun Kim et al. International Journal of Stem Cells
- MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation
- (2013) J. K. Rho et al. CANCER RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Hepatocyte Growth Factor Sensitizes Brain Tumors to c-MET Kinase Inhibition
- (2013) Y. Zhang et al. CLINICAL CANCER RESEARCH
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- Glioblastoma Resistance to Anti-VEGF Therapy: Has the Challenge Been MET?
- (2013) J. H. McCarty CLINICAL CANCER RESEARCH
- HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
- (2013) Shinya Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
- (2013) J. Jean Cui JOURNAL OF MEDICINAL CHEMISTRY
- S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
- (2013) M. F. Burbridge et al. MOLECULAR CANCER THERAPEUTICS
- Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110
- (2013) A. Schulte et al. NEURO-ONCOLOGY
- Inhibition of EGFR Induces a c-MET-Driven Stem Cell Population in Glioblastoma
- (2013) Hyun Jung Jun et al. STEM CELLS
- Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets
- (2012) Hua Mao et al. CANCER INVESTIGATION
- The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype
- (2012) F. De Bacco et al. CANCER RESEARCH
- MET Signaling Regulates Glioblastoma Stem Cells
- (2012) K. M. Joo et al. CANCER RESEARCH
- The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer
- (2012) Fabiola Cecchi et al. Current Signal Transduction Therapy
- Targeting the HGF/Met signaling pathway in cancer therapy
- (2012) Fabiola Cecchi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MiR-410 regulates MET to influence the proliferation and invasion of glioma
- (2012) Lingchao Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives
- (2012) Mark H. Norman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series
- (2012) Longbin Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells
- (2012) Kang Ho Kim et al. NEURO-ONCOLOGY
- Transposon mutagenesis identifies genes that transform neural stem cells into glioma-initiating cells
- (2012) H. Koso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
- (2011) Matija Snuderl et al. CANCER CELL
- A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients
- (2011) R. Tiedt et al. CANCER RESEARCH
- Rapid Radiographic and Clinical Improvement After Treatment of a MET-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor
- (2011) Andrew S. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
- (2011) Francesca De Bacco et al. JNCI-Journal of the National Cancer Institute
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- Gene silencing by microRNAs: contributions of translational repression and mRNA decay
- (2011) Eric Huntzinger et al. NATURE REVIEWS GENETICS
- Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
- (2011) Federico Mingozzi et al. NATURE REVIEWS GENETICS
- Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme
- (2011) H J Jun et al. ONCOGENE
- c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
- (2011) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
- (2011) Neelesh Sharma et al. Therapeutic Advances in Medical Oncology
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- c-MET as a potential therapeutic target and biomarker in cancer
- (2011) J. Rafael Sierra et al. Therapeutic Advances in Medical Oncology
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102, a Fully Human Hepatocyte Growth Factor-Neutralizing Monoclonal Antibody, in a First-in-Human Study of Patients with Advanced Solid Tumors
- (2010) M. S. Gordon et al. CLINICAL CANCER RESEARCH
- Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
- (2010) Ian M. Buchanan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
- (2010) Camilla Krakstad et al. Molecular Cancer
- The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine
- (2010) Toshikazu NAKAMURA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
- (2009) J. P. Eder et al. CLINICAL CANCER RESEARCH
- Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
- (2009) Qinghai Liu et al. JOURNAL OF NEURO-ONCOLOGY
- Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy
- (2009) Y. Li et al. MOLECULAR CANCER THERAPEUTICS
- The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
- (2009) James W Welsh et al. Radiation Oncology
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started